Biofrontera Inc. (BFRIW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
애널리스트 추정 주당순이익(EPS) $-3.04 및 매출 $0.04B 다음 회계연도.
주당순이익(EPS) 실적 추이: 2024: 실적 $0.00 vs 추정 $-3.04 (상회 +99.9%). 2025: 실적 $-1.04 vs 추정 $-1.39 (상회 +25.2%). 애널리스트 정확도: 0%.
EPS 전망 — BFRIW
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.00
vs Est –$3.04
▲ 94,743.8% off
2025
Actual –$1.04
vs Est –$1.39
▲ 33.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
매출 전망 — BFRIW
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.037B
vs Est $0.039B
▼ 5.4% off
2025
Actual $0.042B
vs Est $0.041B
▲ 2.3% off
Revenue Trend
Moderate revenue growth trend. Analysts expect stable revenue going forward.
